Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 99 of 159 for:    Urinary Tract Infections | Recruiting, Not yet recruiting, Available Studies | "Communicable Diseases"

Fecal Microbiota Transplantation (FMT): PRIM-DJ2727

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03786900
Expanded Access Status : Available
First Posted : December 25, 2018
Last Update Posted : December 25, 2018
Sponsor:
Information provided by (Responsible Party):
Herbert DuPont, The University of Texas Health Science Center, Houston

Brief Summary:

The Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 is prepared from human stool from a healthy, screened donor.

Requestors will contact the study team about the product (PRIM-DJ2727) by email, visit, or phone call. A screening list for donors will be provided to make sure that the list fits the requestor's requirements. A basic fee will be requested to recover the cost of making the product. After an agreement is made, a contract will be signed between the 2 parties. A week before the treatment, requestors will contact the study team for possible FMT product delivery. Delivery method will be confirmed for delivery by personnel (within 10 minutes driving distance) or by using FedEx services. Each delivered product will have an approved delivery form signed and dated by both the person who prepared the delivery and the person who received the package.


Condition or disease Intervention/treatment
Recurrent Clostridium Difficile Infection Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection Biological: Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727

Layout table for study information
Study Type : Expanded Access
Expanded Access Type : Individual Patients




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Criteria

Inclusion Criteria:

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03786900


Contacts
Layout table for location contacts
Contact: Herbert L DuPont, MD 713 500 9366 herbert.l.dupont@uth.tmc.edu
Contact: Zhi-Dong Jiang, MD, DrPH 713-500-9371 zhi-dong.jiang@uth.tmc.edu

Sponsors and Collaborators
Herbert DuPont
Investigators
Layout table for investigator information
Principal Investigator: Herbert DuPont, MD The University of Texas Health Science Center, Houston

Layout table for additonal information
Responsible Party: Herbert DuPont, Professor, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT03786900     History of Changes
Other Study ID Numbers: PRIM-DJ2727
First Posted: December 25, 2018    Key Record Dates
Last Update Posted: December 25, 2018
Last Verified: December 2018

Additional relevant MeSH terms:
Layout table for MeSH terms
Infection
Communicable Diseases
Urinary Tract Infections
Clostridium Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Pneumonia
Lung Diseases
Urologic Diseases